Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer

Jae Won Yun; Sejoon Lee; Sejong Chun; Kwang Woo Lee; Jongsu Kim; Hong Sook Kim

doi:10.1002/ctm2.420

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer

Jae Won Yun
, Sejoon Lee
, Sejong Chun
, Kwang Woo Lee
, Jongsu Kim
, Hong Sook Kim

Department of Biological Sciences

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Article number	e420
Journal	Clinical and Translational Medicine
Volume	11
Issue number	5
DOIs	https://doi.org/10.1002/ctm2.420
State	Published - May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/ctm2.420

Cite this

@article{eeef918c649c4db59eaaf36399f70618,

title = "Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer",

author = "Yun, \{Jae Won\} and Sejoon Lee and Sejong Chun and Lee, \{Kwang Woo\} and Jongsu Kim and Kim, \{Hong Sook\}",

year = "2021",

month = may,

doi = "10.1002/ctm2.420",

language = "English",

volume = "11",

journal = "Clinical and Translational Medicine",

issn = "2001-1326",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer

AU - Yun, Jae Won

AU - Lee, Sejoon

AU - Chun, Sejong

AU - Lee, Kwang Woo

AU - Kim, Jongsu

AU - Kim, Hong Sook

PY - 2021/5

Y1 - 2021/5

UR - https://www.scopus.com/pages/publications/85106879315

U2 - 10.1002/ctm2.420

DO - 10.1002/ctm2.420

M3 - Letter

C2 - 34047472

AN - SCOPUS:85106879315

SN - 2001-1326

VL - 11

JO - Clinical and Translational Medicine

JF - Clinical and Translational Medicine

IS - 5

M1 - e420

ER -

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this